0001610717-23-000286.txt : 20230918
0001610717-23-000286.hdr.sgml : 20230918
20230918175810
ACCESSION NUMBER: 0001610717-23-000286
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230914
FILED AS OF DATE: 20230918
DATE AS OF CHANGE: 20230918
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lenz Robert A.
CENTRAL INDEX KEY: 0001992908
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41802
FILM NUMBER: 231262034
MAIL ADDRESS:
STREET 1: C/O NEUMORA THERAPEUTICS, INC.
STREET 2: 490 ARSENAL WAY, SUITE 200
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Neumora Therapeutics, Inc.
CENTRAL INDEX KEY: 0001885522
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 844367680
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 ARSENAL WAY, SUITE 200
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: (857) 760-0900
MAIL ADDRESS:
STREET 1: 490 ARSENAL WAY, SUITE 200
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: RBNC Therapeutics, Inc.
DATE OF NAME CHANGE: 20210929
4
1
form4.xml
X0508
4
2023-09-14
0001885522
Neumora Therapeutics, Inc.
NMRA
0001992908
Lenz Robert A.
C/O NEUMORA THERAPEUTICS, INC.
490 ARSENAL WAY, SUITE 200
WATERTOWN
MA
02472
true
Head of R&D
false
Common Stock
2023-09-14
4
A
0
352941
0
A
352941
D
Stock Option (Right to Buy)
17
2023-09-14
4
A
0
502934
0
A
2033-09-13
Common Stock
502934
502934
D
Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/4th of the RSUs vest annually on September 11 of each year, with the first 1/4th vesting on September 11, 2024.
25% of the shares subject to the option vest on the first anniversary measured from September 11, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
/s/ Joshua Pinto, as Attorney-in-Fact for Robert A. Lenz
2023-09-18